The expression of T-Helper associated transcription factors and cytokine genes in pre-eclampsia

Iranian Journal of Immunology

Volumn 13, Issue 4, 2016, Pages 296-308

  Gharesi Fard, Behrouz ^a,b   Mobasher Nejad, Fatemeh ^a   Nasri, Fatemeh ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cytokines expression; IL 35; Pre eclampsia; Transcription factor

Indexed keywords

CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 31; INTERLEUKIN 35; INTERLEUKIN 4; INTERLEUKIN 6; MESSENGER RNA; RETINOID RELATED ORPHAN RECEPTOR GAMMA; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR GATA 3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA1; TRANSFORMING GROWTH FACTOR BETA2; TRANSFORMING GROWTH FACTOR BETA3; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CASE CONTROL STUDY; CLINICAL ARTICLE; CONTROLLED STUDY; DECIDUA; DOWN REGULATION; FEMALE; GENE EXPRESSION; HELPER CELL; HUMAN; PLACENTA; PREECLAMPSIA; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REGULATORY T LYMPHOCYTE; RNA EXTRACTION; TH1 CELL; TH17 CELL; TH2 CELL; THIRD TRIMESTER PREGNANCY; UPREGULATION; GENETICS; IMMUNOLOGY; METABOLISM; MIDDLE AGED; PRE-ECLAMPSIA; PREGNANCY; RISK FACTOR; T LYMPHOCYTE SUBPOPULATION; YOUNG ADULT;

ADULT; CASE-CONTROL STUDIES; CYTOKINES; FEMALE; GENE EXPRESSION; HUMANS; MIDDLE AGED; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RISK FACTORS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, HELPER-INDUCER; TRANSCRIPTION FACTORS; YOUNG ADULT;

EID: 85016925275     PISSN: 17351383     EISSN: 1735367X     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Steegers EA, von Dadelszen P, Duvekot JJ, Pijnenborg R. Pre-eclampsia. Lancet. 2010; 376, 631-644.
2. Turner JA. Diagnosis and management of pre-eclampsia: an update. Int J Women’s Health. 2010; 30, 327-37.
3. Laresgoiti-Servitje E. A leading role for the immune system in the pathophysiology of preeclampsia. J Leukoc Biol. 2013; 94, 247-57.
4. Gilbert JS, Ryan MJ, LaMarca BB, Sedeek M, Murphy SR, Granger JP. Pathophysiology of hypertension during preeclampsia: linking placental ischemia with endothelial dysfunction. Am J Physiol Heart Circ physiol. 2008; 294, H541-50.
5. Erlebacher A. Mechanisms of T cell tolerance towards the allogeneic fetus. Nat Rev Immunol. 2013; 13, 23-33.
6. Keelan JA, Mitchell MD. Placental cytokines and preeclampsia. Front. Biosci. 2007; 12, 2706-2727.
7. Van Mourik MSK, Macklon NS, Heijnen CJ. Embryonic implantation: cytokines, adhesion molecules, and immune cells in establishing an implantation environment. J Leukoc Biol. 2009; 85, 4-19.
8. Mjosberg j, Berg G, Jenmalm MC, Ernerudh J. FOXP3 Regulatory T Cells and T Helper 1, T Helper 2, and T Helper 17 Cells in Human Early Pregnancy Decidua. Biol Reprod. 2010; 82, 698-705.
9. Croy BA, Chen Z, Hofmann AP, Lord EM, Sedlacek AL, Gerber SA. Imaging of vascular development in early mouse decidua and its association with leukocytes and trophoblasts. Biol Reprod. 2012; 87,125.
10. Zhu J, Yamane H, Paul WE. Differentiation of effector CD4 T cell populations. Annu Rev Immunol. 2010; 28, 445-89.
11. Lissauer D, Goodyear O, Khanum R, Moss PA, Kilby MD. Profile of maternal CD4 T-cell effector function during normal pregnancy and in women with a history of recurrent miscarriage. Clin Sci 2014; 126, 347-354.
12. Polese B, Gridelet V, Araklioti E, Martens H, Perrier d’Hauterive S, Geenen V. The endocrine milieu and CD4 T-lymphocyte polarization during pregnancy. Front. Endocrinol (Lausanne). 2014; 5,106.
13. Luckheeram RV, Zhou R, Verma AD, Xia B. CD4+T Cells: Differentiation and Functions. Clin Dev Immunol. 2012; 2012: 925135.
14. Perrigoue JG, Saenz SA, Siracusa MC, Allenspach EJ, Taylor BC, Giacomin PR, et al. MHC class II-dependent basophil-CD4+ T cell interactions promote T(H)2 cytokine-dependent immunity. Nat immunol. 2009; 10, 697-705.
15. Dillon SR, Sprecher C, Hammond A, Bilsborough J, Rosenfeld-Franklin M, Presnell SR, et al. Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice. Nat Immunol. 2004; 5, 752-760.
16. Saito S, Sakai M. Th1/ Th2 balance in preeclampsia. J Reprod Immunol. 2003; 59, 161-173.
17. Jianjun Z, Yali H, Zhiqun W, Mingming Z, Xia Z. Imbalance of T-cell transcription factors contributes to the Th1 type immunity predominant in pre-eclampsia. Am J Reprod Immunol. 2009; 63, 38-45.
18. Ivanov II, McKenzie BS, Zhou L, Tadokoro CE, Lepelley A, Lafaille JJ, et al. The orphan nuclear receptor ROR gammat directs the differentiation program of proinflammatory IL17+ T helper cells. Cell. 2006; 126, 1121-33.
19. Zambrano-Zaragoza JF, Romo-Martínez EJ, Durán-AvelarMde J, García-Magallanes N, Vibanco-Pérez N. Th17 Cells in Autoimmune and Infectious Disease. Int J Inflamm. 2014; 651503.
20. Ghoreschi K, Laurence A, Yang XP, Tato CM, McGeachy MJ, Konkel JE, et al. Generation of pathogenic TH17 cells in the absence of TGF-β signaling. Nature. 2010; 467, 967-971.
21. Mangan PR, Harrington LE, O’Quinn DB, Helms WS, Bullard DC, Elson CO, et al. Transforming growth factor-beta induces development of the T H17 lineage. Nature. 2006; 441, 231-234.
22. Crome SQ, Wang AY, Levings MK. Translational mini-review series on Th17 cells: function and regulation of human T helper 17 cells in health and disease. Clin Exp Immunol. 2010; 159, 109-119.
23. Maddur MS, Miossec P, Kaveri SV, Bayry J. Th17 cells: biology, pathogenesis of autoimmune and inflammatory diseases, and therapeutic strategies. Am J Pathol. 2012; 181, 8-18.
24. Fu B, Tian Z, Wei H. TH17 cells in human recurrent pregnancy loss and pre-eclampsia. Cell Mole Immunol. 2014; 11, 564-570.
25. Santner-Nanan B, Peek MJ, Khanam R, Richarts L, Zhu E, Fazekas de St Groth B, et al. Systemic increase in the ratio between Foxp3+ and IL-17-producing CD4+T cells in healthy pregnancy but not in preeclampsia. J Immunol. 2009; 183, 7023-7030.
26. Hori S, Nomura T, Sakaguchi S. Control of regulatory T cell development by the transcription factor Foxp3. Science. 2003; 299, 1057-61.
27. Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, et al. TGF-β-induced Foxp3 inhibits TH17 cell differentiation by antagonizing RORγt function. Nat. 2008; 453, 236-240.
28. Sakaguchi S, Ono M, Setoguchi R, Yagi H, Hori S, Fehervari Z, et al. Foxp3+CD25+ CD4+ natural regulatory T cells in dominant self-tolerance and autoimmune disease. Immunol Rev 2006; 212, 8-27.
29. Yang J, Yang M, Htut TM, Ouyang X, Hanidu A, Li X, et al. Epstein-Barr virus-induced gene 3 negatively regulates IL-17, IL-22 and RORgamma t. Eur J Immunol. 2008; 38, 1204-14.
30. Tilburgs T, Roelen DL, van der Mast BJ, van Schip JJ, Kleijburg C, de Groot-Swings GM, et al. Differential distribution of CD4+CD25bright and CD8+CD28- T-cells in decidua and maternal blood during human pregnancy. Placenta. 2006; 27,S47-S53.
31. Sasaki Y, Darmochwal-Kolarz D, Suzuki D, Sakai M, Ito M, Shima T, et al. Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in pre-eclampsia. Clin Exp Immunol. 2007; 149, 139-45.
32. Whitehead GS, Wilson RH, Nakano K, Burch LH, Nakano H, Cook DN. IL-35 production by inducible costimulator (ICOS)-positive regulatory T cells reverses established IL-17-dependent allergic airways disease. J Allergy Clin Immunol. 2012; 129, 207-215.
33. Evergne O, Coulomb-L’Hermine A, Capel F, Moussa M, Capron F. Expression of Epstein-Barr virus-induced gene 3, an interleukin-12 p40-related molecule, throughout human pregnancy: Involvement of syncytiotrophoblasts and extravilloustrophoblasts. Am J Pathol. 2001; 159, 1763-1776.
34. Saito S, Shiozaki A, Nakashima A, Sakai M, Sasaki Y. The role of the immune system in preeclampsia. Mol Aspects Med. 2007; 28, 192-209.
35. Saito S, Umekage H, Sakamoto Y, Sakai M, Tanebe K, Sasaki Y, et al. Increased T-helper-1-type immunity and decreased T-helper-2-type immunity in patients with preeclampsia. Am J Reprod Immunol. 1999; 41, 297-306.
36. Peck A, Mellins ED. Plasticity of T-cell phenotype and function: the T helper type 17 example. Immunology. 2010; 129, 147-53.
37. Tilburgs T, Roelen DL, van der Mast BJ, de Groot-Swings GM, Kleijburg C, Scherjon SA, et al. Evidence for a selective migration of fetus specific CD4+ CD25 bright regulatory T cells from the peripheral blood to the decidua in human pregnancy. J Immunol. 2008; 180, 5737-5745.
38. Prins J, Boelens H, Heimweg J, Van der Heide S, Dubois A, Van Oosterhout A, et al. Preeclampsia is associated with lower percentages of regulatory T cells in maternal blood. Hypertens. Pregnancy. 2009; 1, 1-12.
39. Toldi G, Svec P, Vasarhelyi B, Rigo J, Tulassay T, Treszl A. Decreased number of FoxP3+ regulatory T cells in preeclampsia. Acta Obstet Gynecol Scand. 2008; 87, 1229-1233.
40. Aluvihare VR, Kallikourdis M, Betz AG. Regulatory Tcells mediate maternal tolerance to the fetus. Nat Immunol. 2004; 5, 266-271.
41. Dabagh-Gorjani F, Anvari F, Zolghadri J, Kamali-Sarvestani E, Gharesi-Fard B. Differences in the expression of TLRs and inflammatory cytokines in pre-eclamptic compared with healthy pregnant women. Iran J Immunol. 2014; 11, 233-45.
42. Toldi G, Saito S, Shima T, Halmos A, Veresh Z, Vásárhelyi B, et al. The frequency of peripheral blood CD4+ CD25high FoxP3+ and CD4+ CD25- FoxP3+ regulatory T cells in normal pregnancy and pre-eclampsia. Am J Reprod Immunol. 2012; 68, 175-80.
43. Toldi G, Vásárhelyi ZE, RigóJJr, Orbán C, Tamássy Z, Bajnok A, et al. Prevalence of Regulatory T-Cell Subtypes in Preeclampsia. Am J Reprod Immunol. 2015; 74, 110-5.
44. Cao W, Wang X, Chen T, Zhu H, Xu W, Zhao S, et al. The Expression of Notch/Notch Ligand, IL-35, IL-17, and Th17/Treg in Preeclampsia. Dis Markers. 2015,31618.
45. Szarka A, RigóJJr, Lázár L, Beko G, Molvarec A. Circulating cytokines, chemokines and adhesion molecules in normal pregnancy and preeclampsia determined by multiplex suspension array. BMC Immunol. 2010; 2,11:59.
46. Toldi G, RigóJJr, Stenczer B, Vásárhelyi B, Molvarec A. Increased prevalence of IL-17-producing peripheral blood lymphocytes in pre-eclampsia. 2011; 66, 223-9.
47. Molvarec A, Czegle I, Szijártó J. Increased circulating interleukin-17 levels in preeclampsia. J Reprod Immunol. 2015; 112, 53-7.
48. Collison LW, Workman CJ, Kuo TT, Boyd K, Wang Y, Vignali KM, et al. The inhibitory Cytokine IL-35 contributes to regulatory T-cell function. Nature. 2007; 450, 566-569.